FASEB moves from bench to bedside

Next executive director embodies shift in organization's direction.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

SAN DIEGO — A medical doctor rather than a bench researcher has been selected as the new Executive Director of the Federation of American Societies for Experimental Biology (FASEB), the world's largest organization of basic research scientists. According to Frederick R. Rickles, professor of medicine and pediatrics at George Washington University, his appointment highlights FASEB's shift in recent years toward translational, or "bench-to-bedside," research, although the focus of the organization stops short of being purely clinical, he said.

"FASEB used to be viewed as a society that focused primarily on basic research," explained Rickles, "but with the inclusion of societies such as the American Society of Clinical Investigation and others, the research focus has expanded. My selection for the position of executive director is perhaps a logical progression representing that shift."

FASEB's 60,000 members are drawn from 14 member societies and eight associate societies, making it the largest coalition of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Emma Hitt

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours